Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer
D Cao, Q Song, J Li, Y Jiang, Z Wang… - Expert reviews in …, 2021 - cambridge.org
Pancreatic cancer is one of the most malignant tumours with a poor prognosis. In recent
years, the incidence of pancreatic cancer is on the rise. Traditional chemotherapy and …
years, the incidence of pancreatic cancer is on the rise. Traditional chemotherapy and …
Pancreatic cancer: diagnosis and treatments
HY Li, ZM Cui, J Chen, XZ Guo, YY Li - Tumor Biology, 2015 - Springer
Pancreatic cancer is one of the deadliest cancers, with exceptionally high mortality. Despite
the relatively low incidence rate (10th), it is the fourth leading cause of cancer-related deaths …
the relatively low incidence rate (10th), it is the fourth leading cause of cancer-related deaths …
Efecto del silenciamiento del gen WT-1 con ARNi en combinación con drogas anticancerígenas en modelo In vitro y en un modelo murino con metástasis a pulmón.
FG Thompson Armendáriz - 2018 - eprints.uanl.mx
La proteína del tumor de Wilms (WT1) tiene un papel en la regulación genes del
crecimiento, diferenciación y proliferación celular, suprime el crecimiento celular y …
crecimiento, diferenciación y proliferación celular, suprime el crecimiento celular y …